Hutchison China MediTech Ltd ADR buy melinda
Start price
12.03.18
/
50%
€33.42
Target price
12.09.18
€40.59
Performance (%)
-26.30%
End price
12.09.18
€24.63
Summary
This prediction ended on 12.09.18 with a price of €24.63. The price of Hutchison China MediTech Ltd ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.30%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | 9.783% | 9.783% | 56.589% | - |
| iShares Core DAX® | 2.749% | 4.620% | 17.121% | 21.210% |
| iShares Nasdaq 100 | 0.470% | -0.331% | 37.776% | 57.865% |
| iShares Nikkei 225® | -2.930% | -5.556% | 12.185% | 8.407% |
| iShares S&P 500 | 0.679% | 0.631% | 28.996% | 48.197% |
Comments by melinda for this prediction
In the thread Hutchison China MediTech Ltd ADR diskutieren
Pharmazeutische SecteurProduits Agenda 12/03 | 08.00 Uhr veröffentlichte Ergebnisse
Hutchison China Meditech wendet sich an die erste Arzneimittelzulassung in diesem Jahr
(Laufzeit überschritten)